IP Library Granted Patent US 8,852,915
Granted Patent B2
US 8,852,915 · App. 13/650,594 · Granted Oct 7, 2014

Method of retrovirus storage

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,852,915
App. No.
13/650,594
Granted
Oct 7, 2014
Kind
B2
Abstract

A method of retrovirus storage, characterized in that a retrovirus is sustained in the presence of a substance with retrovirus binding activity immobilized on a solid phase. Further, there is provided a retrovirus composition characterized in that a retrovirus in the form of binding to a substance with retrovirus binding activity is sealed in a container holding a solid phase having the substance with retrovirus binding activity immobilized thereon.

Claims (13)

1. A method for stably storing a retrovirus, comprising:

(1) contacting a solid support on which a substance having a retrovirus-binding activity is immobilized with a retrovirus producer cell culture supernatant which contains the retrovirus;

(2) removing the retrovirus producer cell culture supernatant in step (1) from contact with the solid support;

(3) after removal of the retrovirus producer cell culture supernatant, contacting the solid support on which the retrovirus is bound via the substance having a retrovirus-binding activity immobilized on the solid support with a solution containing at least one substance selected from the group consisting of gelatin, albumin and lactose; and

(4) storing the retrovirus, bound to the solid support via the substance having a retrovirus-binding activity immobilized on the solid support obtained in step (3), in contact with the solution and in an unfrozen state for a period of 24 hours or more.

2. The method according to claim 1 , wherein the retrovirus is stored in contact with the solution so that the solution is not in contact with air.

3. The method according to claim 1 , wherein the solution contains a phosphate salt as a buffering component.

4. The method according to claim 1 , wherein one substance of the at least one substance contained in the solution is bovine serum albumin (BSA) or human serum albumin (HSA).

5. The method according to claim 1 , wherein the period of storage is 48 hours or more.

6. The method according to claim 5 , wherein the period of storage is 72 hours or more.

7. The method according to claim 1 , wherein the storing step is carried out at a temperature of 15° C. or below.

8. The method according to claim 7 , wherein the storing step is carried out at a temperature of 0-10° C.

9. The method according to claim 1 , wherein the solid support is a container selected from the group consisting of a culture plate, a culture flask, a separation bag, and a gas-permeable culture bag.

Assignments (1)
CHANGE OF ADDRESS Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →